Compare United States Brent Oil Fund LP (BNO) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United States Brent Oil Fund LP vs Citius Pharmaceuticals Inc — how do they compare? United States Brent Oil Fund LP trades at $50.7, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: United States Brent Oil Fund LP is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| BNO | CTXR | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $60.13 | $1.82 |
52-Week Low | $27.20 | $0.48 |
Market Cap | — | $20.01M |
Enterprise Value | — | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
